The effect of endothelial progenitor cells on angiotensin II-Induced proliferation of cultured rat vascular smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 6, 2011, Pages 617-625

  Fang, Li ^a   Chen, Mei Fang ^a   Xiao, Zhi Lin ^a   Yu, Guo Long ^a   Chen, Xiao Bin ^a   Xie, Xiu Mei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Ang II; EPCs; MAPK NF B (p65); proliferation; VSMCs

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOTENSIN II; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; CARDIOVASCULAR DISEASE; CELL ASSAY; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PHOSPHORYLATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 83155184664     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318230bb5f     Document Type: Article

References (37)

1. Ward M R, Stewart DJ, Kutryk Michael JB. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: Current perspectives. Catheter Cardiovasc Interv. 2007;70:983-998.
2. Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res. 2004;95:343-353. (Pubitemid 39100452)
3. He T, Smith LA, Harrington S, et al. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit arteries. Stroke. 2004;35:2378-2384. (Pubitemid 39311267)
4. Griese DP, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: Implications for cell-based vascular therapy. Circulation. 2003;108:2710-2715. (Pubitemid 37466815)
5. Zargham R. Preventing restenosis after angioplasty: A multistage approach. Clin Sci (Lond). 2008;114:257-264. (Pubitemid 351294001)
6. Inoue T, Node K. Molecular basis of restenosis and novel issues of drugeluting stents. Circ J. 2009;73:615-621.
7. Mugabe BE, Yaghini FA, Song CY, et al. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogenactivated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation. J Pharmacol Exp Ther. 2010;332:116-124.
8. Dzau VJ, Gnecchi M, Pachori AS, et al. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension. 2005; 46:7-18. (Pubitemid 40946479)
9. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-3427. (Pubitemid 30183318)
10. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
11. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967. (Pubitemid 27087709)
12. Duan HX, Cheng LM, Wang J, et al. Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biol Int. 2006;30:1018-1027.
13. Shaffer RG, Greene S, Arshi A, et al. Flow cytometric measurement of circulating endothelial cells: The effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom. 2006;70:56-62.
14. Yasu T. Differentiation of endothelial progenitor cells: A useful biomarker? Circ J. 2009;73:1199-1200.
15. Handgretinger R, Gordon PR, Leimig T, et al. Biology and plasticity of CD133-hematopoietic stem cells. Ann N Y Acad Sci. 2003;996: 141-151. (Pubitemid 36706596)
16. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702-712. (Pubitemid 36749219)
17. Hu CH, Li ZM, Du Zm, et al. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction. Chin Med J (Engl). 2009;122:548-555.
18. He J, Xie XM, Jiang DJ, et al. Differentiation of 2 endothelial progenitor cells in vitro and inhibitory effect of a symmetric dimethylarginine on its proliferation. J Cent South Univ (Med Sci). 2008;33:138-145.
19. Melero-Martin JM, Khan ZA, Picard A, et al. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood. 2007;109:4761-4768. (Pubitemid 46827769)
20. Wang HY, Gao PJ, Ji KD, et al. Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease. Hypertens Res. 2007;30:133-141.
21. Nagaya N, Kangawa K, Kanda M, et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation. 2003;108:889-895. (Pubitemid 37022134)
22. Takahashi M, Nakamura T, Toba T, et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng. 2004;10:771-779. (Pubitemid 38880395)
23. Matsuo Y, Imanishi T, Hayashi Y, et al. The effect of senescence of endothelial progenior cells on in-stent restenosis in patients undergoing coronary stenting. Intern Med. 2006;45:581-588.
24. Fang L, Chen MF, Yu GL, et al. Effect of endothelial progenitor cells on the proliferation of co-cultured vascular smooth muscle cells. J Cent South Univ (Med Sci). 2010;35:52-62.
25. Yoon CH, Hut J, Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005;112:1618-1627.
26. Heeschen C, Lehman R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109: 1615-1622. (Pubitemid 38451717)
27. Chang WC, Yu YM, Chiang SY, et al. Ellagic acid suppresses oxidized low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. Br J Nutr. 2008;99: 709-714.
28. Zhan Y, Kim S, Izumi Y, et al. Role of JNK, p38, and ERK in plateletderived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol. 2003;23:795-801. (Pubitemid 36566168)
29. Taniyama Y, Ushio-Fukai M, Hitomi H, et al. Role of p38MAPK and MAPKAPK22 in angiotensin II induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2004;287:494-499.
30. Hoshi S, Goto M, Koyama N, et al. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, IkappaB. J Biol Chem. 2000;275:883-889. (Pubitemid 30051130)
31. Wang Z, Castresana MR, Detmer K, et al. An IkappaB-alpha mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res. 2002;102:198-206 (Pubitemid 34969468)
32. Zheng S, Qian Z, Wen N, et al. Crocetin suppresses angiotensin IIinduced vascular smooth-muscle cell proliferation through inhibition of ERK1/2 activation and cell-cycle progression. J Cardiovasc Pharmacol. 2007;50:519-525. (Pubitemid 350146454)
33. Wang S, Liu Y, Fan F, et al. Inhibitory effects of emodin on the proliferation of cultured rat vascular smooth muscle cell-induced by angiotensin II. Phytother Res. 2008;22:247-251. (Pubitemid 351363246)
34. Xia JH, Xie AN, Zhang KL, et al. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J. 2006;119:117-121.
35. Murasawa S, Kawamoto A, Horii M, et al. Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol. 2005;25: 1388-1394. (Pubitemid 40923357)
36. Santhanam AV, Smith LA, He T, et al. Endothelial progenitor cells stimulate cerebrovascular production of prostacyclin by paracrine activation of cyclooxygenase-2. Circulation Res. 2007;100:1379-1388. (Pubitemid 46742928)
37. Vajkoczy P, Blum S, Lamparter M, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med. 2003;197:1755-1765. (Pubitemid 36745350)